Magnetic Resonance Imaging of Cardiovascular Manifestations Following COVID‐19

Globally, over 650 million people have had COVID-19 due to infection with the SARS-Cov-2 virus. Cardiac complications in the acute infectious and early recovery phase were recognized early in the pandemic, including myocardial injury and inflammation. With a decrease in the number of acute COVID-19 related deaths, there has been increased interest in postacute sequela of COVID-19 (PASC) and other longer-term cardiovascular complications. A proportion of patients recovered from COVID-19 have persistent cardiac symptoms and are at risk of cardiovascular disease. Cardiovascular imaging, including MRI, plays an important role in the detection of cardiovascular manifestations of COVID-19 in both the acute and longer-term phases after COVID-19. The purpose of this review is to highlight the role of cardiovascular imaging in the diagnosis and risk stratification of patients with acute and chronic cardiovascular manifestations of COVID-19 with a focus on cardiac MRI. EVIDENCE LEVEL: 4. TECHNICAL EFFICACY: Stage 3.

[1]  J. Fish,et al.  Myocardial Inflammation at FDG PET/MRI and Clinical Outcomes in Symptomatic and Asymptomatic Participants after COVID-19 Vaccination , 2023, Radiology. Cardiothoracic imaging.

[2]  M. Bivas-Benita,et al.  Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study , 2023, BMJ.

[3]  P. Kellman,et al.  Cardiovascular magnetic resonance imaging and spectroscopy in clinical long-COVID-19 syndrome: a prospective case–control study , 2022, Journal of Cardiovascular Magnetic Resonance.

[4]  Simon S. Martin,et al.  Long-term cardiac pathology in individuals with mild initial COVID-19 illness , 2022, Nature Network Boston.

[5]  P. Thavendiranathan,et al.  Thoracic and Cardiac Imaging / Imagerie cardiaque et imagerie thoracique , 2022 .

[6]  Chi-Yen Wang,et al.  Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks , 2022, eClinicalMedicine.

[7]  B. Wintersperger,et al.  Clinical Impact of Cardiac MRI T1 and T2 Parametric Mapping in Patients with Suspected Cardiomyopathy. , 2022, Radiology.

[8]  A. Sadiq,et al.  COVID-19 Resulting in Global Stress Cardiomyopathy in a Young Female , 2022, Cureus.

[9]  George A. Koromia,et al.  2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19 , 2022, Journal of the American College of Cardiology.

[10]  C. Maertens de Noordhout,et al.  Pathophysiology and mechanism of long COVID: a comprehensive review , 2022, Annals of medicine.

[11]  R. Wald,et al.  Cardiac MRI and Clinical Follow-up in COVID-19 Vaccine–associated Myocarditis , 2022, Radiology.

[12]  R. Wald,et al.  Myocarditis Following COVID-19 Vaccination , 2022, Cardiology Clinics.

[13]  Stephen J. Huang,et al.  Echocardiography findings in COVID-19 patients admitted to intensive care units: a multi-national observational study (the ECHO-COVID study) , 2022, Intensive Care Medicine.

[14]  M. Nangaku,et al.  Impact of COVID-19 pandemic on healthcare service use for non-COVID-19 patients in Japan: retrospective cohort study , 2022, BMJ Open.

[15]  P. Thavendiranathan,et al.  Imaging of Myocarditis Following mRNA COVID-19 Booster Vaccination , 2022, Radiology. Cardiothoracic imaging.

[16]  S. Lalwani,et al.  ACE2 protein expression in lung tissues of severe COVID-19 infection , 2022, Scientific Reports.

[17]  Matthew W. Martinez,et al.  2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play , 2022, Journal of the American College of Cardiology.

[18]  A. Kara,et al.  Multisystem inflammatory syndrome in children associated with COVID‐19 in 101 cases from Turkey (Turk‐MISC study) , 2022, Journal of paediatrics and child health.

[19]  O. Blagova,et al.  Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19 , 2022, Diagnostic Pathology.

[20]  R. Wald,et al.  Myocardial Injury Pattern at MRI in COVID-19 Vaccine–Associated Myocarditis , 2022, Radiology.

[21]  Benjamin Bowe,et al.  Long-term cardiovascular outcomes of COVID-19 , 2022, Nature Medicine.

[22]  M. Roffi,et al.  Coronavirus disease 2019-associated coronary endotheliitis and thrombotic microangiopathy causing cardiogenic shock: a case report , 2022, European heart journal. Case reports.

[23]  V. Ferrari,et al.  The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury , 2022, JACC: Basic to Translational Science.

[24]  J. Fish,et al.  Combined Cardiac Fluorodeoxyglucose-Positron Emission Tomography/Magnetic Resonance Imaging Assessment of Myocardial Injury in Patients Who Recently Recovered From COVID-19. , 2022, JAMA cardiology.

[25]  S. Barry,et al.  Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection , 2021, BMC Medicine.

[26]  A. Órfão,et al.  Pericardial and myocardial involvement after SARS-CoV-2 infection: a cross-sectional descriptive study in healthcare workers , 2021, Revista Española de Cardiología (English Edition).

[27]  Deepak L. Bhatt,et al.  2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2021, Circulation.

[28]  A. Gundlapalli,et al.  Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 , 2021, MMWR. Morbidity and mortality weekly report.

[29]  A. Faron,et al.  Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19 , 2021, Radiology.

[30]  K. Chappell,et al.  Chronic SARS-CoV-2, a Cause of Post-acute COVID-19 Sequelae (Long-COVID)? , 2021, Frontiers in Microbiology.

[31]  S. Kato,et al.  Coronavirus disease (COVID-19) associated delayed-onset fulminant myocarditis in patient with a history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection , 2021, Journal of Infection and Chemotherapy.

[32]  G. Di Salvo,et al.  Early Echocardiographic and Cardiac MRI Findings in Multisystem Inflammatory Syndrome in Children , 2021, Journal of clinical medicine.

[33]  Siraj Ahmed Ali,et al.  Global burden of acute myocardial injury associated with COVID-19: A systematic review, meta-analysis, and meta-regression , 2021, Annals of Medicine and Surgery.

[34]  Z. Mahfoud,et al.  Systematic review and meta-analysis of chest radiograph (CXR) findings in COVID-19 , 2021, Clinical Imaging.

[35]  K. Rychlik,et al.  Cardiovascular magnetic resonance imaging in children after recovery from symptomatic COVID-19 or MIS-C: a prospective study , 2021, Journal of Cardiovascular Magnetic Resonance.

[36]  G. Lip,et al.  Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews , 2021, European heart journal. Quality of care & clinical outcomes.

[37]  Manish M Patel,et al.  Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2 , 2021, JAMA network open.

[38]  C. Esopenko,et al.  Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection , 2021, JAMA cardiology.

[39]  R. Young,et al.  Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues , 2021, Proceedings of the National Academy of Sciences.

[40]  P. Kellman,et al.  Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers , 2021, JACC: Cardiovascular Imaging.

[41]  S. Podder,et al.  Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity , 2021, Computers in Biology and Medicine.

[42]  I. Valverde,et al.  Imaging findings of multisystem inflammatory syndrome in children associated with COVID-19 , 2021, Pediatric Radiology.

[43]  P. Trambaiolo,et al.  Right Ventricular Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis , 2021, Journal of Cardiothoracic and Vascular Anesthesia.

[44]  R. Sullivan,et al.  Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis. , 2021, Journal of the American College of Cardiology.

[45]  G. Finocchiaro,et al.  COVID-19 and myocarditis: a systematic review and overview of current challenges , 2021, Heart Failure Reviews.

[46]  D. Brodie,et al.  Post-acute COVID-19 syndrome , 2021, Nature Medicine.

[47]  Yu-Xuan Cai,et al.  Echocardiographic Characteristics and Outcome in Patients With COVID-19 Infection and Underlying Cardiovascular Disease , 2021, Frontiers in Cardiovascular Medicine.

[48]  D. Pennell,et al.  Short-Term sequelae of Multisystem Inflammatory Syndrome in Children Assessed by CMR. , 2021, JACC. Cardiovascular imaging.

[49]  P. Kellman,et al.  Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance , 2021, European heart journal.

[50]  M. Mansourian,et al.  COVID-19 infection in children: A systematic review and meta-analysis of clinical features and laboratory findings , 2021, Archives de Pédiatrie.

[51]  M. Jenkinson,et al.  Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge , 2020, EClinicalMedicine.

[52]  M. Revel,et al.  Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis , 2020, Radiology.

[53]  B. Clary,et al.  Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis , 2020, EClinicalMedicine.

[54]  J. Leipsic,et al.  Use of cardiac CT amidst the COVID-19 pandemic and beyond: North American perspective , 2020, Journal of Cardiovascular Computed Tomography.

[55]  V. Fuster,et al.  Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia , 2020, Journal of the American College of Cardiology.

[56]  H. Schultheiss,et al.  Proof of SARS-CoV-2 genomes in endomyocardial biopsy with latency after acute infection , 2020, International Journal of Infectious Diseases.

[57]  Yan Yang,et al.  The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis , 2020, Clinical cardiology.

[58]  B. Spieler,et al.  A Characteristic Chest Radiographic Pattern in the Setting of the COVID-19 Pandemic , 2020, Radiology. Cardiothoracic imaging.

[59]  C. Siu,et al.  Patients Recovered From COVID-19 Show Ongoing Subclinical Myocarditis as Revealed by Cardiac Magnetic Resonance Imaging , 2020, JACC: Cardiovascular Imaging.

[60]  S. Kabir,et al.  Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19 , 2020, European heart journal cardiovascular Imaging.

[61]  P. Kirchhof,et al.  Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. , 2020, JAMA cardiology.

[62]  Eike Nagel,et al.  Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[63]  W. Manning,et al.  COVID-19-Associated Stress (Takotsubo) Cardiomyopathy. , 2020, Circulation. Cardiovascular imaging.

[64]  C. Hamm,et al.  Detection of viral SARS‐CoV‐2 genomes and histopathological changes in endomyocardial biopsies , 2020, ESC heart failure.

[65]  E. Blondiaux,et al.  Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series , 2020, Radiology.

[66]  Hesong Zeng,et al.  Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging , 2020, JACC: Cardiovascular Imaging.

[67]  B. Lämmle,et al.  Severe COVID-19 infection associated with endothelial activation , 2020, Thrombosis Research.

[68]  K. Yuen,et al.  Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 , 2020, Cell.

[69]  D. Diz,et al.  COVID-19, ACE2, and the cardiovascular consequences , 2020, American journal of physiology. Heart and circulatory physiology.

[70]  W. Gong,et al.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.

[71]  Jie Hao,et al.  Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection , 2020, Frontiers of Medicine.

[72]  G. Pontone,et al.  Prognostic Value of Repeating Cardiac Magnetic Resonance in Patients With Acute Myocarditis. , 2019, Journal of the American College of Cardiology.

[73]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. , 2018, Journal of the American College of Cardiology.

[74]  H. Lee,et al.  Utility of Dual-Energy CT-based Monochromatic Imaging in the Assessment of Myocardial Delayed Enhancement in Patients with Cardiomyopathy. , 2017, Radiology.

[75]  G. Pontone,et al.  Cardiac MR With Late Gadolinium Enhancement in Acute Myocarditis With Preserved Systolic Function: ITAMY Study. , 2017, Journal of the American College of Cardiology.

[76]  R. Blankstein,et al.  Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis. , 2017, Journal of the American College of Cardiology.

[77]  H. Lee,et al.  Myocardial Extracellular Volume Fraction with Dual-Energy Equilibrium Contrast-enhanced Cardiac CT in Nonischemic Cardiomyopathy: A Prospective Comparison with Cardiac MR Imaging. , 2016, Radiology.

[78]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[79]  Rosa M. Estrada-Y.-Martin,et al.  CTPA as the gold standard for the diagnosis of pulmonary embolism , 2011, International Journal of Computer Assisted Radiology and Surgery.

[80]  G. Navis,et al.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.